Chronic lymphocytic leukemia in India-A clinico-hematological profile
- 1 June 2007
- journal article
- research article
- Published by Taylor & Francis Ltd in Hematology
- Vol. 12 (3), 229-233
- https://doi.org/10.1080/10245330701255064
Abstract
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in elderly people. The clinico-hematological profile and treatment outcome of patients with CLL were assessed using retrospective case record analysis over 11 years. There were 95 (75 males: 20 females) patients with a median age of 61 years. Thirty patients were aged 55 years or less (young CLL patients) and 65 were more than 55 years of age (elder CLL patients). Sixty percent patients had non-specific complaints, such as weakness, cough and indigestion. Twenty-six (27%) patients had pallor and 24 (25%) had fever as initial presenting manifestation. Bleeding manifestations were seen in 7 patients. Seven patients were diagnosed incidentally. Lymphadenopathy, splenomegaly and hepatomegaly were seen in 52 (55%), 63 (66%) and 60 (63%) patients, respectively. The median white blood cell count and absolute lymphocyte counts were 70,600 and 51,490/μl, respectively. Three patients had autoimmune hemolytic anemia. Twenty-five patients (26%) had anemia with hemoglobin 3/mm3 was seen in 17 (18%). Interstitial nodular, mixed and diffuse bone marrow (BM) involvement was seen in 10.2, 67.3, 6.1 and 16.3% cases, respectively. Eighteen (60%) young patients and 35 (54%) older patients required treatment with chlorambucil. The mean time from initial diagnosis to treatment was 4.6 ± 10.7 months. None of our patient attained complete response. Six patients obtained partial response. Median duration of chlorambucil was 7 months (1–86 months). Forty-six patients had stable disease. Three patients died. Median survival of study group was 4 years (8 months–13 years). In older CLL it was 4 years (8 months–11 years) and in young patients, survival duration was 5.5 years (1–13 years).Keywords
This publication has 12 references indexed in Scilit:
- Comparison of younger versus older B-cell chronic lymphocytic leukemia patients for clinical presentation and prognosis. A retrospective study of 53 casesEuropean Journal of Haematology, 2009
- Clinical Characteristics and Outcome of Young Chronic Lymphocytic Leukemia Patients: A Single Institution Study of 204 CasesBlood, 1999
- Chlorambucil in Indolent Chronic Lymphocytic LeukemiaThe New England Journal of Medicine, 1998
- Long‐term clinical outcome of B‐cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic levelBritish Journal of Haematology, 1997
- Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemiaThe Lancet, 1996
- Advances in the biology and treatment of B-cell chronic lymphocytic leukemiaBlood, 1995
- Presenting features and prognosis of chronic lymphocytic leukemia in younger adults [see comments]Blood, 1991
- CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3Leukemia & Lymphoma, 1991
- Chronic Lymphocytic Leukemia in Younger Adults: Preliminary Results of a Study Based on 454 Patients—IWCLL/Working GroupLeukemia & Lymphoma, 1991
- Clinical staging of chronic lymphocytic leukemiaBlood, 1975